Aspect Biosystems, Novo Nordisk to develop implants to treat diabetes and obesity
The partnership will leverage Aspect’s bioprinting technology and Novo Nordisk’s expertise in stem cell differentiation and cell therapy…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
13 Apr 23
The partnership will leverage Aspect’s bioprinting technology and Novo Nordisk’s expertise in stem cell differentiation and cell therapy…
12 Apr 23
Revolutionary smart bladder control system provides new option, allowing patients to conduct therapy at-home without surgery, implants, or…
11 Apr 23
Avantis platform uses small electrical impulses and delivers them to the spinal cord to help restore arm, shoulder,…
06 Apr 23
Exclusively developed for the treatment of brain tumours, lesions, and other conditions of the head and neck, the…
06 Apr 23
AMUG representatives presented the DINO Awards in recognition of tenure in the additive manufacturing industry, years of service,…
05 Apr 23
Primed to revolutionize quality management and compliance for the life sciences industry, Dot Compliance's ready-to-use generative and predictive…
03 Apr 23
Coloplast has finalised its first pivotal clinical study on Luja, a new intermittent male catheter, designed to reduce…
31 Mar 23
Histotripsy is said to be a non-invasive platform and novel sonic beam therapy that targets and removes primary…
28 Mar 23
With its data, people, and analytics solutions, SUAZIO provides market insights to the global medical technology sector
28 Mar 23
Researchers from the Centers for Disease Control and Prevention (CDC) recently published a study showing that C.auris has…